Dr. Chester Melvin Hedgepeth III, MD

Dr. Hedgepeth practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Dr. Hedgepeth's NPI, 1063409233, was assigned on October 4, 2005. Dr. Hedgepeth graduated from Perelman School of Medicine - Philadelphia in 2000. Dr. Hedgepeth's Massachusetts license number on file is 216367.

Dr. Hedgepeth's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Dr. Hedgepeth's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. Dr. Hedgepeth is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Hedgepeth to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hedgepeth practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hedgepeth's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Hedgepeth is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Hedgepeth's licenses on file in 2 states: Massachusetts and Rhode Island.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, cerebrovascular disease, chronic hypertension, congestive heart failure and coronary artery disease among the conditions Dr. Hedgepeth treats.

CMS data shows 2,132 Medicare services from Dr. Hedgepeth across 10 procedure codes in 2024, for 1,291 Medicare patients. Medicare paid $63,880 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,291 Medicare patients who saw Dr. Hedgepeth in 2024. The largest group is 75 to 84, with 526 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hedgepeth's median patient age at 73, with 50% women.

In 2024, Dr. Hedgepeth wrote 4,059 Medicare Part D claims for 451 patients. 75% of them were for generic drugs. CMS names the drug for 3,863 of them, across 42 drugs with 11 or more claims each, at $766,291 in total drug cost. In 2023, CMS named 3,496 claims across 47 drugs.

Dr. Hedgepeth accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Hedgepeth to 1 clinical trial. Conditions studied include Ventricular Fibrillation and Death, Sudden.

CMS Open Payments shows 6 general payments to Dr. Hedgepeth from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $136.

Dr. Hedgepeth graduated from Perelman School of Medicine - Philadelphia in 2000.

Dr. Hedgepeth is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.